PharmaGraphX

Log in Get Started

Alogliptin

Nesina, Kazano, Oseni

Uncategorized

Standard

Half-life

21 hours

Protein Binding

20%

Metabolized By

N/A

External

Drugs.com

Mechanism of action

Selectively inhibits DPP-4

Recorded indications

From the drug index — may include conditions studied rather than approved indications

·T2DM
·MAFLD
·Diabetes Mellitus, Type 2
·Cardiovascular Events
·Type2 Diabetes

Interactions

No curated interaction pairs are recorded for Alogliptin. This is not a statement that none exist — check a full interaction reference before combining.

Common adverse effects

Nasopharyngitis
Headache
Upper respiratory infection

Food, alcohol & herbal

Alcohol · moderate

May increase hypoglycemia risk

Pharmacokinetics

Half-life: 21 hours
Protein binding: 20%

Pregnancy & lactation

Not recorded for Alogliptin. Absence here means this database does not hold a category — not that the drug is safe in pregnancy or breastfeeding.

Sources

Assembled from: drug index, curated drug database.

Not a substitute for clinical judgement